Gongwin Biopharm Holdings Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 9.12 million. Net loss was TWD 16.88 million compared to TWD 96.22 million a year ago. Basic loss per share from continuing operations was TWD 0.15 compared to TWD 0.85 a year ago.
For the nine months, sales was TWD 10.27 million. Net loss was TWD 59.01 million compared to TWD 185.42 million a year ago. Basic loss per share from continuing operations was TWD 0.52 compared to TWD 1.68 a year ago.